Page last updated: 2024-11-04

vorinostat and Gastrointestinal Stromal Tumors

vorinostat has been researched along with Gastrointestinal Stromal Tumors in 1 studies

Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).

Gastrointestinal Stromal Tumors: All tumors in the GASTROINTESTINAL TRACT arising from mesenchymal cells (MESODERM) except those of smooth muscle cells (LEIOMYOMA) or Schwann cells (SCHWANNOMA).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mühlenberg, T1
Zhang, Y1
Wagner, AJ1
Grabellus, F1
Bradner, J1
Taeger, G1
Lang, H1
Taguchi, T1
Schuler, M1
Fletcher, JA1
Bauer, S1

Other Studies

1 other study available for vorinostat and Gastrointestinal Stromal Tumors

ArticleYear
Inhibitors of deacetylases suppress oncogenic KIT signaling, acetylate HSP90, and induce apoptosis in gastrointestinal stromal tumors.
    Cancer research, 2009, Sep-01, Volume: 69, Issue:17

    Topics: Acetylation; Apoptosis; Cell Line, Tumor; Enzyme Inhibitors; Gastrointestinal Stromal Tumors; Histon

2009